Young car thieves are making life miserable and complicated for a Sanger family of six.The family spent hundreds of dollars ...

The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline ...

Maxine became the first African American to teach at the University of Texas Medical Branch, Health. the first woman on ...

Journey Medical (DERM) received FDA approval for its drug Emrosi for the treatment of rosacea and released its preliminary Q3 ...

Aslı Tarcan Clinic is a well-known hair transplant facility in Istanbul and has reported increased visits from international ...

MedPage Today spoke with Ungerleider about her experience as a physician and medical journalist reporting on her own family's ...

Financial toxicity is a burden many patients and their families unfortunately are forced to shoulder, leading some to delay ...

Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of ...

The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...

Alliance Global Partners analyst Scott Henry raised the firm’s price target on Journey Medical (DERM) to $11 from $8.50 and reiterated a Buy rating on the shares. The firm noted the “underwhelmed” ...

In a world where weight management is increasingly prioritized, appetite suppressants have gained immense popularity for ...

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...